These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28500763)

  • 21. Hypoxia induces metalloproteinase-9 activation and human vascular smooth muscle cell migration through low-density lipoprotein receptor-related protein 1-mediated Pyk2 phosphorylation.
    Revuelta-López E; Castellano J; Roura S; Gálvez-Montón C; Nasarre L; Benitez S; Bayes-Genis A; Badimon L; Llorente-Cortés V
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2877-87. PubMed ID: 24072693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural Hematoma.
    Hua C; Zhao G; Feng Y; Yuan H; Song H; Bie L
    J Neurotrauma; 2016 Jan; 33(1):65-70. PubMed ID: 25646653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcuma oil attenuates accelerated atherosclerosis and macrophage foam-cell formation by modulating genes involved in plaque stability, lipid homeostasis and inflammation.
    Singh V; Rana M; Jain M; Singh N; Naqvi A; Malasoni R; Dwivedi AK; Dikshit M; Barthwal MK
    Br J Nutr; 2015 Jan; 113(1):100-13. PubMed ID: 25391643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis.
    Söder PO; Meurman JH; Jogestrand T; Nowak J; Söder B
    J Periodontal Res; 2009 Aug; 44(4):452-8. PubMed ID: 18973519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of plasma ox-LDL and carotid IMT may represent useful markers for atherosclerosis and may represent potential targets for therapeutic interventions.
    Savoiu G; Drăgan S; Cristescu C; Serban C; Noveanus L; Ionescu D; Nicola T; Duicu O; Raducan A; Voicu M
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):397-401. PubMed ID: 21491821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development.
    Georgiadi A; Wang Y; Stienstra R; Tjeerdema N; Janssen A; Stalenhoef A; van der Vliet JA; de Roos A; Tamsma JT; Smit JW; Tan NS; Müller M; Rensen PC; Kersten S
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1529-37. PubMed ID: 23640487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine.
    Wigren M; Kolbus D; Dunér P; Ljungcrantz I; Söderberg I; Björkbacka H; Fredrikson GN; Nilsson J
    J Intern Med; 2011 May; 269(5):546-56. PubMed ID: 21114693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers.
    Sier CF; Casetta G; Verheijen JH; Tizzani A; Agape V; Kos J; Blasi F; Hanemaaijer R
    Clin Cancer Res; 2000 Jun; 6(6):2333-40. PubMed ID: 10873084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical implications of urine matrix metalloproteinases and their inhibitors in patients with chronic glomerulonephritis].
    Li OA; Bobkova IN; Kozlovckaia LV
    Ter Arkh; 2009; 81(8):10-4. PubMed ID: 19799193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hormone replacement therapy in matrix metalloproteinase expression and intimal hyperplasia development after vascular injury.
    Mountain DJ; Freeman MB; Kirkpatrick SS; Cook RB; Chalk JE; Stevens SL; Goldman MH; Grandas OH
    Ann Vasc Surg; 2013 Apr; 27(3):337-45. PubMed ID: 23088810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
    Meier P; Meier R; Blanc E
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory T Cell Immunity in Atherosclerosis.
    Amin HZ; Sasaki N; Hirata KI
    Acta Med Indones; 2017 Jan; 49(1):63-68. PubMed ID: 28450656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T-cell immunity and its relevance to atherosclerosis.
    Taleb S; Tedgui A; Mallat Z
    J Intern Med; 2008 May; 263(5):489-99. PubMed ID: 18410592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidized low-density lipoprotein-induced CD147 expression and its inhibition by high-density lipoprotein on platelets in vitro.
    Yang SH; Li YT; Du DY
    Thromb Res; 2013; 132(6):702-11. PubMed ID: 24144446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinase-9 modulates intestinal injury in rats with transmural colitis.
    Medina C; Santana A; Paz MC; Díaz-Gonzalez F; Farre E; Salas A; Radomski MW; Quintero E
    J Leukoc Biol; 2006 May; 79(5):954-62. PubMed ID: 16478919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease.
    Jia L; Zhu L; Wang JZ; Wang XJ; Chen JZ; Song L; Wu YJ; Sun K; Yuan ZY; Hui R
    Atherosclerosis; 2013 Jun; 228(2):346-52. PubMed ID: 23566804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions.
    Borrelli V; di Marzo L; Sapienza P; Colasanti M; Moroni E; Cavallaro A
    Surgery; 2006 Sep; 140(3):454-63. PubMed ID: 16934609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.
    Nilsson J; Fredrikson GN; Björkbacka H; Chyu KY; Shah PK
    J Intern Med; 2009 Sep; 266(3):221-31. PubMed ID: 19702790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphocytes in atherosclerosis.
    Wigren M; Nilsson J; Kolbus D
    Clin Chim Acta; 2012 Oct; 413(19-20):1562-8. PubMed ID: 22565046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory T Cell-Enhancing Therapies to Treat Atherosclerosis.
    Ait-Oufella H; Lavillegrand JR; Tedgui A
    Cells; 2021 Mar; 10(4):. PubMed ID: 33805071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.